INO
INOVIO PHARMACEUTICALS, INC.
Key Financials
Operating Income
$-86822104
↑ 22.8%
Revenue
$65343
↓ 70.0%
Net Income
$-84945901
↑ 20.8%
EPS (Diluted)
$-1.81
↑ 54.2%
Total Assets
$74.3M
↓ 34.4%
Cash & Equivalents
$44.3M
↓ 32.7%
Long-term Debt
$62.8M
N/A
Total Liabilities
$50.2M
↑ 12.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 8/12/2026 | View on SEC |
| 10-Q | 8/12/2026 | View on SEC |
| SCHEDULE 13G/A | 8/12/2026 | View on SEC |
| SCHEDULE 13G | 8/7/2026 | View on SEC |
| SCHEDULE 13G/A | 8/6/2026 | View on SEC |
| SCHEDULE 13G | 7/31/2026 | View on SEC |
| 8-K | 7/31/2026 | View on SEC |
| 424B5 | 7/30/2026 | View on SEC |
| 8-K | 7/29/2026 | View on SEC |
| 424B5 | 7/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INO |
| Company Name | INOVIO PHARMACEUTICALS, INC. |
| CIK | 1055726 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 8584103134 |